Faculty
Picture of Havlichek
         
Daniel Havlichek, Jr., M.D.
     
Chief, Division of Infectious Diseases
Professor of Medicine
       

Dr. Daniel Havlichek graduated from the University of Michigan Medical School in 1981. He did his Internal Medicine Residency and Infectious Disease Fellowship at Henry Ford Hospital in Detroit, Michigan. Dr. Havlichek joined the faculty at Michigan State University in 1986 and has held a variety of clinical, educational and administrative positions in the Department of Medicine since then.

He is currently Professor of Medicine and Microbiology, Chief of the College of  Human Medicine Infectious Diseases Division, and Program Director for the Infectious  Diseases Fellowship. Dr. Havlichek is course director for the second year medical  student course on Infectious Diseases and Immunology and also teaches regularly in  the College of Osteopathic Medicine and for the Graduate Medical Inc, Internal  Medicine Residency program. Dr. Havlichek's academic interests include diagnosis and management of skin and soft tissue infections, HIV, and infectious disease prevention.

 

Mary Nettleman, MD, MS
Professor of Medicine

Dr. Nettleman received her Medical Degree from Vanderbilt University. She completed her residency and an Infectious Disease Fellowship at Indiana University. She also holds a Master's Degree in Preventive Medicine from the University of Iowa. Dr. Nettleman is an expert on infection control, travel medicine, tuberculosis and sexually transmitted diseases. She is an active researcher with more than 100 articles in peer-reviewed journals. Dr. Nettleman's areas of research include infectious disease epidemiology and women's health issues. She is Chair of the Department of Medicine and Associate Chair of the MSU Biomedical IRB.

Among Dr. Nettleman's memberships are: American College of Physicians (Fellow), Society for General Interal Medicine, Central Society for Clinical Research and Infectious Diseases Society of America.

Picture of Gulick
  Peter Gulick, DO
Associate Professor of Medicine
College of Osteopathic Medicine

Dr. Peter Gulick received his BS degree from Mount Union College, Alliance, Ohio and his DO degree from Chicago College of Osteopathic Medicine. He received training in two specialities: Infectious Disease at Cleveland Clinic Foundation and Medical Oncology at Roswell Park Memorial Institute. The American Board of Internal Medicine dually certifies him in Medical Oncology and Infectious Disease.

He is currently Associate Professor of Medicine at Michigan State University College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of nursing. He is also Director of the MSU HIV/Hepatitis Clinic. His area of interest is HIV therapy as well as Hepatitis B, C and coinfection therapy.

In addition to teaching, Dr. Gulick provides patient care in his Oncology Clinic at the Great Lakes Cancer Institute/MSU Breslin Center and in his Infectious Disease Clinic in Lansing, Michigan. He has taken care of HIV patients for 20 years and Hepatitis C patients for 10 years.

Dr. Gulick is a member of the American Osteopathic Association, American Medical Association, American Microbiology Society, Infectious Disease Society of America, the Michigan Chapter of the American Liver Foundation, the Inter-American Society of Chemotherapy and the American Federation of Clinical Research. He is appointed by the State of Michigan, Department of Community Health to the Lung Cancer Advisory Committee, the HIV/AIDS Prevention and Intervention Section, the Michigan Cancer Consortium and the Region 1 Smallpox Planning Team (RSPT). On the local level he serves on the Infection Control Committees in the hospitals, and on the advisory boards for the school system. He is an educational advisor to a number of pharmaceutical companies as well as a medical advisor in the legal system.

 

Picture of Stein
Gary Stein, PharmD.
Professor of Medicine

Professor Stein is a clinical pharmacologist who specializes in antimicrobial pharmacodynamics and pharmacoeconomics. He is also actively involved in clinical  trials of new agents and vaccines.

Infectious Disease Department of Medicine Michigan State University